- Home
- PAVM vs BCLI Comparison
PAVM vs BCLI Comparison
Compare PAVM & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAVM
- BCLI
- Stock Information
- Founded
- PAVM 2014
- BCLI 2000
- Country
- PAVM United States
- BCLI United States
- Employees
- PAVM N/A
- BCLI N/A
- Industry
- PAVM Medical/Dental Instruments
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAVM Health Care
- BCLI Health Care
- Exchange
- PAVM Nasdaq
- BCLI Nasdaq
- Market Cap
- PAVM 12.0M
- BCLI 9.8M
- IPO Year
- PAVM 2016
- BCLI N/A
- Fundamental
- Price
- PAVM $0.61
- BCLI $1.20
- Analyst Decision
- PAVM Strong Buy
- BCLI Strong Buy
- Analyst Count
- PAVM 1
- BCLI 1
- Target Price
- PAVM $19.00
- BCLI $30.00
- AVG Volume (30 Days)
- PAVM 162.2K
- BCLI 526.0K
- Earning Date
- PAVM 08-11-2025
- BCLI 08-13-2025
- Dividend Yield
- PAVM N/A
- BCLI N/A
- EPS Growth
- PAVM N/A
- BCLI N/A
- EPS
- PAVM 0.96
- BCLI N/A
- Revenue
- PAVM $1,993,000.00
- BCLI N/A
- Revenue This Year
- PAVM N/A
- BCLI N/A
- Revenue Next Year
- PAVM $455.63
- BCLI N/A
- P/E Ratio
- PAVM $0.61
- BCLI N/A
- Revenue Growth
- PAVM N/A
- BCLI N/A
- 52 Week Low
- PAVM $0.55
- BCLI $0.72
- 52 Week High
- PAVM $1.90
- BCLI $6.60
- Technical
- Relative Strength Index (RSI)
- PAVM 36.65
- BCLI 52.98
- Support Level
- PAVM $0.59
- BCLI $1.08
- Resistance Level
- PAVM $0.65
- BCLI $1.32
- Average True Range (ATR)
- PAVM 0.04
- BCLI 0.10
- MACD
- PAVM -0.00
- BCLI 0.01
- Stochastic Oscillator
- PAVM 5.09
- BCLI 54.88
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.